Brief: Sinopharm Group Posts Qtrly Net Profit Attributable For Sinopharm Accord Of RMB322.1 Mln
Oct 22 (Reuters) - China National Accord Medicines Corp
Ltd 000028.SZ :
* QTRLY NET PROFIT ATTRIBUTABLE FOR SINOPHARM ACCORD
RMB322.1
MILLION
* QTRLY REVENUE FOR SINOPHARM ACCORD RMB18.68 BILLION
Further company coverage: 000028.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For